Page 5 - Ionis Pharmaceuticals Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) Receives $49 07 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Privium Fund Management B V Has $10 36 Million Holdings in Ionis Pharmaceuticals, Inc (NASDAQ:IONS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals, Inc (NASDAQ:IONS) is Privium Fund Management B V s 8th Largest Position
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Raised to Hold at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ionis Pharmaceuticals (NASDAQ:IONS) Lifted to Hold at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.